Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer (2011)
- Authors:
- Olsen, Elise A
- Whittaker, Sean
- Kim, Youn H
- Duvic, Madeleine
- Prince, H Miles
- Lessin, Stuart R
- Wood, Gary S
- Willemze, Rein
- Demierre, Marie-France
- Pimpinelli, Nicola
- Bernengo, Maria Grazia
- Ortiz-Romero, Pablo L
- Bagot, Martine
- Estrach, Teresa
- Guitart, Joan
- Knobler, Robert
- Sanches Júnior, José Antonio
- Iwatsuki, Keiji
- Sugaya, Makoto
- Dummer, Reinhard
- Pittelkow, Mark
- Hoppe, Richard
- Parker, Sareeta
- Geskin, Larisa
- Pinter-Brown, Lauren
- Girardi, Michael
- Burg, Günter
- Ranki, Annamari
- Vermeer, Maartan
- Horwitz, Steven
- Heald, Peter
- Rosen, Steve
- Cerroni, Lorenzo
- Dreno, Brigette
- Vonderheid, Eric C
- Autor USP: SANCHES JUNIOR, JOSE ANTONIO - FM
- Unidade: FM
- DOI: 10.1200/JCO.2010.32.0630
- Subjects: MICOSES (DIAGNÓSTICO); FUNGOS; LINFOMA (TERAPIA); MANIFESTAÇÕES CUTÂNEAS; PROGNÓSTICO; BIÓPSIA; LINFEDEMA (ETIOLOGIA); HEMORRAGIA (ETIOLOGIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of clinical oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 29, n. 18, p. 2598-2607, 2011
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo possui acesso gratuito no site do editor (Bronze Open Access) -
ABNT
OLSEN, Elise A et al. Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. Journal of clinical oncology, v. 29, n. 18, p. 2598-2607, 2011Tradução . . Disponível em: https://doi.org/10.1200/JCO.2010.32.0630. Acesso em: 11 mar. 2026. -
APA
Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., et al. (2011). Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. Journal of clinical oncology, 29( 18), 2598-2607. doi:10.1200/JCO.2010.32.0630 -
NLM
Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre M-F, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches Júnior JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC. Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer [Internet]. Journal of clinical oncology. 2011 ; 29( 18): 2598-2607.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1200/JCO.2010.32.0630 -
Vancouver
Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre M-F, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches Júnior JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC. Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer [Internet]. Journal of clinical oncology. 2011 ; 29( 18): 2598-2607.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1200/JCO.2010.32.0630 - Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study
- Dermoscopy of primary cutaneous B- and T-cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case-control study with histopathologic correlation
- Case for diagnosis. Erythematous-violaceous reticulated plaques on the breasts [Editorial]
- Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil
- Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
- Consensuses, guidelines and position papers [Editorial]: the role of the Brazilian Society of Dermatology in the contribution to the best practice of Dermatology
- Tumores malignos de linhagem hematológica
- Velvety Palms [Editorial]
- Clinical end points and response criteria in mycosis fungoides and sézary syndrome: A consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer
- Melanoma cutaneo primario
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
